| 2020 |
Fassio A, Adami G, Giollo A, Viapiana O, Malavolta N, Saviola G, Bortolotti R, Idolazzi L, Bertoldo F, Rossini M, Gatti D. Acute effects of glucocorticoid treatment, TNFΑ or IL-6R blockade on bone turnover markers and wnt inhibitors in early rheumatoid arthritis: a pilot study. Calcif Tiss Int. April 2020;106(4):371-377. |
0 |
0 |
| 2021 |
Fassio A, Adami G, Idolazzi L, Giollo A, Viapiana O, Bosco E, Negrelli R, Sani E, Sandri D, Mantovani A, Targher G, Rossini M, Gatti D. Diffuse Idiopathic Skeletal Hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker. Calcif Tiss Int. February 2021;108(2):231-239. |
0 |
0 |
| 2020 |
Adami G, Fassio A, Giollo A, Orsolini G, Viapiana O, Gatti D, Rossini M. Could previous exposure to nitrogen‐containing bisphosphonates mitigate friendly fire? J Bone Miner Res. October 2020;35(10):2082-2082. |
0 |
0 |
| 2022 |
Adami G, Fassio A, Gatti D, Viapiana O, Rossini M. Acute phase reaction and fracture risk reduction: are gamma-delta T cells and hypovitaminosis D the missing link? J Bone Miner Res. August 2022;37(8):1622-1622. |
0 |
0 |
| 2023 |
Adami G, Gatti D, Fassio A, Viapiana O, Rossini M. Cardiovascular safety of romosozumab: new insights from postmenopausal women with chronic kidney disease. J Bone Miner Res. February 2023;38(2):354-355. |
0 |
0 |
| 2020 |
Adami G, Rossini M, Fassio A, Viapiana O, Gatti D. Comments on Kanis et al. Algorithm for the management of patients at low, high, and very high risk of osteoporotic fractures. Osteoporos Int. May 2020;31(5):1015-1015. |
2 |
1 |
| 2020 |
Adami G, Gatti D, Rossini M, Orsolini G, Pollastri F, Bertoldo E, Viapiana O, Bertoldo F, Giollo A, Fassio A. Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort. Osteoporos Int. November 2020;31(11):2113-2122. |
0 |
0 |